IndiaMTF — home
Stock

Neuland Laboratories — MTF Book

NEULANDLAB · Neuland Laboratories Limited
Health Technology

Daily Margin Trading Facility book for Neuland Laboratories across NSE and BSE, from 01 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.

What is Neuland Laboratories’s MTF book?

Neuland Laboratories Limited (NEULANDLAB) has ₹124 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.08% of India’s MTF book, ranking #306. Over 1M (the last 30 trading days) the funded value has risen 57.6%, with the number of shares under margin up 49.3%.

Funded value
₹124 Cr
as of 23 Oct 2026
Rank in book
#306
1,471 days tracked
Share of book
0.08%
of the whole NSE + BSE book
Peak funded
₹168 Cr
on 13 May 2026
Largest single-day addition
+₹37 Cr
on 11 May 2026
Largest single-day unwind
−₹24 Cr
on 23 Jun 2026
Free-float market cap
₹16,396 Cr
full market cap ₹24,204 Cr · 67.7% free float · Small cap
MTF share of free float
0.72%
0.3× the median small cap · 0.8× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

0.23%0.52%0.81%1.11%Jun 2024Oct 2026
View as table: share of free float on margin28 months
Month-end% of free float
23 Oct 20260.717%
30 Sep 20260.630%
31 Aug 20260.532%
31 Jul 20260.544%
30 Jun 20260.492%
29 May 20261.005%
30 Apr 20260.550%
30 Mar 20260.610%
27 Feb 20260.721%
30 Jan 20260.696%
31 Dec 20250.691%
28 Nov 20250.642%
31 Oct 20250.527%
30 Sep 20250.699%
29 Aug 20250.666%
31 Jul 20250.703%
30 Jun 20250.646%
30 May 20250.576%
30 Apr 20250.479%
28 Mar 20250.438%
28 Feb 20250.376%
31 Jan 20250.366%
31 Dec 20240.478%
24 Oct 2024†0.333%
30 Sep 20240.444%
09 Aug 2024†0.519%
31 Jul 20240.605%
28 Jun 20240.786%

† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).

Dated events

NSE & BSE split

How NEULANDLAB’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹119 Cr · 96.4%BSE ₹4 Cr · 3.6%

MTF vs Price

Margin-funded outstanding for NEULANDLAB in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹18,865.00
as of 23 Oct 2026
Price, 1M
−18.7%
adjusted for splits and bonuses
Delivery, 20-day avg
48.5%
of traded volume actually settled
Sessions to unwind
3
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹2−1.4%−1.2%
−758
−0.4%unwinding as it falls
10D+₹10+8.8%+9.4%
+5,354
−10.2%building as it falls
1M+₹45+57.6%+49.3%
+20,578
−21.4%building as it falls
3M+₹56+82.5%+51.2%
+21,117
+2.4%building into strength
6M+₹58+89.7%+34.6%
+16,023
+26.0%building into strength
1Y+₹72+137.0%+59.7%
+23,303
+16.5%building into strength

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where NEULANDLAB has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

NEULANDLAB — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 2026124−₹20.08%306
22 Oct 2026125+₹10.08%306
21 Oct 2026125+₹00.08%312
19 Oct 2026125−₹10.08%314
16 Oct 2026125+₹10.08%314
15 Oct 2026124+₹30.08%315
14 Oct 2026121+₹40.08%321
13 Oct 2026117+₹30.07%337
12 Oct 2026114−₹00.07%343
09 Oct 2026114+₹00.07%340
08 Oct 2026114+₹20.07%341
07 Oct 2026112−₹10.07%349
06 Oct 2026112+₹50.07%344
05 Oct 2026107−₹10.07%363
01 Oct 2026108−₹00.07%359
30 Sep 2026108+₹10.07%358
29 Sep 2026108+₹180.07%360
28 Sep 202689−₹00.06%419
25 Sep 202689+₹40.06%418
24 Sep 202686+₹00.05%431
23 Sep 202685+₹00.06%431
22 Sep 202685−₹20.06%432
21 Sep 202687+₹30.06%425
18 Sep 202684+₹30.05%434
17 Sep 202681+₹00.05%455
16 Sep 202681−₹60.05%459
15 Sep 202687+₹30.06%433
11 Sep 202684−₹10.05%448
10 Sep 202684−₹20.05%442
09 Sep 202686—0.06%438

NEULANDLAB within Health Technology

Ranked #13 of 61 funded Health Technology stocks, carrying 1.8% of that sector’s margin book. Its 0.72% of free float on margin is 0.8× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
11MARKSANSMarksans Pharma₹1382.1%1.98%−1.6%
12LENSKARTLenskart Solutions₹1332.0%0.15%+39.5%
13NEULANDLABNeuland Laboratories₹1241.8%0.72%+57.6%
14BLUEJETBlue Jet Healthcare₹1231.8%4.44%−12.4%
15BIOCONBiocon Limited₹1221.8%0.34%+10.2%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.